Related Experiment Video
Updated: Apr 20, 2026
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Building high-resolution synthetic lethal networks: a 'Google map' of the cancer cell
James M Paul1, Shaina D Templeton2, Akanksha Baharani2
1Department of Biochemistry, University of Saskatchewan, Saskatoon, S7N 5E5 Canada; Department of Pathology, University of Saskatchewan, Saskatoon, S7N 0W8 Canada.
Abstract:
The most commonly used therapies for cancer involve delivering high doses of radiation or toxic chemicals to the patient that also cause substantial damage to normal tissue. To overcome this, researchers have recently resorted to a basic biological concept called 'synthetic lethality' (SL) that takes advantage of interactions between gene pairs. The identification of SL interactions is of considerable therapeutic interest because if a particular gene is SL with a tumor-causing mutation, then the targeting that gene carries therapeutic advantages. Mapping these interactions in the context of human cancer cells could hold the key to effective, targeted cancer treatments. In this review, we cover the recent advances that aim to identify these SL interactions using unbiased genetic screens.
Insights
Synthetic lethality (SL) exploits gene interactions to target cancer cells while sparing normal tissues. Identifying these SL interactions is crucial for developing effective, targeted cancer therapies.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Conventional cancer therapies like radiation and chemotherapy cause significant damage to healthy tissues.
- Synthetic lethality (SL) is a biological principle that offers a targeted approach to cancer treatment.
- SL involves exploiting the interaction between pairs of genes, where the simultaneous disruption of both genes leads to cell death.
Purpose of the Study:
- To review recent advances in identifying synthetic lethality interactions.
- To highlight the potential of mapping SL interactions in human cancer cells for targeted therapies.
Main Methods:
- The review focuses on unbiased genetic screening approaches.
- These methods aim to systematically identify gene pairs exhibiting synthetic lethality.
Main Results:
- Recent advances have enabled the identification of numerous synthetic lethality interactions.
- These findings pave the way for understanding gene interactions in cancer.
Conclusions:
- Mapping synthetic lethality interactions is key to developing effective and targeted cancer treatments.
- Unbiased genetic screens are powerful tools for discovering these therapeutically relevant gene interactions.
More Related Videos
Related Concept Videos
02:26Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
02:53Adaptive Mechanisms in Cancer Cells
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...